Form 4: Codexis CFO Georgia Erbez Reports Acquisition of Shares and Stock Options

Georgia Erbez, CFO of Codexis, reports the acquisition of 50,000 common stock shares and 300,000 stock options.

Summary

• On October 10, 2024, Georgia Erbez, the Chief Financial Officer of Codexis, Inc., reported transactions involving Codexis's securities.
• Erbez acquired 50,000 shares of common stock at a price of $0.
• Following this transaction, Erbez beneficially owns 50,000 shares of common stock.
• Erbez also acquired options to purchase 300,000 shares of common stock at an exercise price of $2.97, exercisable starting October 10, 2024, and expiring on October 10, 2034.
• These options vest over time, with 25% vesting on the first anniversary of September 30, 2024, and the remainder vesting monthly thereafter, contingent upon continued employment.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing. The acquisition of shares and options could be seen as a positive signal, but it's not definitive.

Positives

• The acquisition of shares and options by the CFO could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor management's alignment with shareholder interests.

Comparison to Industry Standards

• Monitoring insider transactions is a common practice in financial analysis.
• Comparing the vesting schedules and exercise prices of these options to those of peer companies (e.g., Amyris, Ginkgo Bioworks) can provide insights into the competitiveness of Codexis's compensation packages.
• Similar filings from executives at companies like Novozymes or DSM could be used as benchmarks.

Stakeholder Impact

• The transactions could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence from the CFO.

Key Dates